DocGo Inc. (NASDAQ:DCGO - Get Free Report) has received an average rating of "Moderate Buy" from the six research firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $3.59.
Several analysts have recently weighed in on DCGO shares. Needham & Company LLC lowered their target price on shares of DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a report on Friday, May 9th. BTIG Research downgraded shares of DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Finally, Canaccord Genuity Group lifted their target price on shares of DocGo from $1.45 to $1.60 and gave the company a "hold" rating in a report on Thursday, August 21st.
Read Our Latest Research Report on DCGO
Institutional Trading of DocGo
Several hedge funds and other institutional investors have recently made changes to their positions in DCGO. JPMorgan Chase & Co. lifted its stake in shares of DocGo by 199.3% in the fourth quarter. JPMorgan Chase & Co. now owns 328,796 shares of the company's stock valued at $1,394,000 after purchasing an additional 218,941 shares during the period. Wells Fargo & Company MN lifted its stake in shares of DocGo by 31.0% in the fourth quarter. Wells Fargo & Company MN now owns 57,463 shares of the company's stock valued at $244,000 after purchasing an additional 13,584 shares during the period. Invesco Ltd. lifted its stake in shares of DocGo by 1.3% in the fourth quarter. Invesco Ltd. now owns 177,953 shares of the company's stock valued at $755,000 after purchasing an additional 2,312 shares during the period. Renaissance Technologies LLC lifted its stake in shares of DocGo by 583.4% in the fourth quarter. Renaissance Technologies LLC now owns 350,600 shares of the company's stock valued at $1,487,000 after purchasing an additional 299,300 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in shares of DocGo in the fourth quarter valued at about $527,000. Institutional investors and hedge funds own 56.44% of the company's stock.
DocGo Stock Performance
DocGo stock traded down $0.01 during midday trading on Friday, hitting $1.65. 79,148 shares of the company's stock were exchanged, compared to its average volume of 838,703. DocGo has a 12-month low of $1.23 and a 12-month high of $5.68. The stock has a market cap of $160.89 million, a price-to-earnings ratio of -8.60 and a beta of 0.96. The firm's 50 day simple moving average is $1.54 and its 200 day simple moving average is $2.23.
DocGo (NASDAQ:DCGO - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.05). The firm had revenue of $80.42 million during the quarter, compared to analysts' expectations of $77.58 million. DocGo had a negative net margin of 4.20% and a negative return on equity of 3.26%. DocGo has set its FY 2025 guidance at EPS. On average, equities research analysts forecast that DocGo will post 0.25 EPS for the current fiscal year.
DocGo Company Profile
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
See Also

Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.